Kexing Biopharm Makes it into China’s Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years

Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized on June 27 as one of “China’s Top 20 Biopharmaceutical Enterprises” (blood products, vaccines and insulin) for two consecutive years. This prestigious sub-list is part of the renowned “2022 China’s Top 100 Pharmaceutical Enterprises”. Kexing Biopharmaceutical’s inclusion can be attributed to its robust research…

thaipr.net

10 ก.ค. 66

Lifera and CENTOGENE, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing

CENTOGENE N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF), have announced a strategic collaboration with the formation of a Joint Venture (JV) to increase local and regional access and rapid delivery of world-class multiomic testing to patients […]

thaipr.net

3 ก.ค. 66

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment of primary hypertension (NCT02901704). The study was led by […]

thaipr.net

30 มิ.ย. 66

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

The Society of Human Reproduction and Embryology (ESHRE) annual meeting witnessed a historic event as people from around the globe gathered both in person and online to set a new world record for the most people consuming a dose of inositol simultaneously. The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic […]

thaipr.net

29 มิ.ย. 66

Nasdaq Bid Price Deficiency Letter

On June 14, 2023, Etao International Co., Ltd. (the “Company”) received a bid price deficiency letter from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that listed securities to maintain a minimum bid price of $1 per share. Based upon the closing bid price for the last 30 consecutive business days, the Company no […]

thaipr.net

23 มิ.ย. 66

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end users demand…

thaipr.net

22 มิ.ย. 66
1 34 35 36 37 38 128